| Bal Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524824 |
NSE Symbol : BALPHARMA |
P/E(TTM) : 20.62 |
|
ISIN Demat : INE083D01012 |
Div & Yield% : 1.22 |
EPS(TTM) : 4.77 |
|
Book Value(₹) : 65.39 |
Market Cap(₹Cr) : 156.58 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 88.43 | 83.92 | 87.49 | 73.75 | 65.64 | 81.78 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 88.43 | 83.92 | 87.49 | 73.75 | 65.64 | 81.78 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.46 | -0.22 | 0.35 | 1.13 | 0.74 | 0.99 |
| Total Income | 88.88 | 83.70 | 87.84 | 74.88 | 66.38 | 82.77 |
| Total Expenditure | 80.48 | 73.29 | 77.82 | 67.98 | 59.48 | 73.95 |
| PBIDT | 8.41 | 10.41 | 10.02 | 6.91 | 6.89 | 8.82 |
| Interest | 4.47 | 4.05 | 4.85 | 3.86 | 4.05 | 3.94 |
| PBDT | 3.94 | 6.36 | 5.17 | 3.05 | 2.84 | 4.88 |
| Depreciation | 2.78 | 3.04 | 3.23 | 2.27 | 2.52 | 2.07 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.30 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | -0.39 | 0.00 | 0.00 | 0.00 | -1.49 |
| Reported Profit After Tax | 1.16 | 3.70 | 1.95 | 0.78 | 0.32 | 5.61 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.16 | 3.70 | 1.95 | 0.78 | 0.32 | 5.61 |
| EPS (Unit Curr.) | 0.73 | 2.60 | 1.22 | 0.49 | 0.20 | 3.51 |
| EPS (Adj) (Unit Curr.) | 0.73 | 2.60 | 1.22 | 0.49 | 0.20 | 3.51 |
| Calculated EPS (Unit Curr.) | 0.73 | 2.32 | 1.22 | 0.49 | 0.20 | 3.52 |
| Calculated EPS (Adj) (Unit Curr.) | 0.73 | 2.32 | 1.22 | 0.49 | 0.20 | 3.52 |
| Calculated EPS (Ann.) (Unit Curr.) | 2.92 | 9.30 | 4.89 | 1.96 | 0.81 | 14.09 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 2.92 | 9.30 | 4.89 | 1.96 | 0.81 | 14.09 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 15.92 | 15.92 | 15.92 | 15.92 | 15.92 | 15.92 |
| Reserve & Surplus | 0.00 | 88.18 | 0.00 | 0.00 | 0.00 | 82.90 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 9.51 | 12.40 | 11.45 | 9.37 | 10.50 | 10.79 |
| PBDTM(%) | 4.46 | 7.58 | 5.91 | 4.14 | 4.33 | 5.97 |
| PATM(%) | 1.31 | 4.41 | 2.23 | 1.06 | 0.49 | 6.86 |
